NCT07033624View on ClinicalTrials.gov

Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study

Not yet recruitingOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2047

Conditions

Cardiovascular Diseases

Trial Locations (1)

150000

The Second Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors

lead

Harbin Medical University

OTHER